Current status of pharmacological interventions for preventing stenosis of arteriovenous hemodialysis access
Abstract
Autogenous arteriovenous fistulas and arteriovenous grafts are currently the most commonly used types of hemodialysis vascular access. Vascular stenosis and secondary thrombosis are the major causes of vascular access dysfunction. At present， the management of vascular access dysfunction relies primarily on surgical interventions， including open surgery and endovascular treatment， whereas pharmacological strategies for prevention have not yet been incorporated into routine clinical practice. This review summarizes recent advances in pharmacological interventions for maintaining vascular access patency and preventing vascular stenosis， with the aim of exploring the potential role and clinical value of pharmacological strategies in preserving vascular access patency.
Related
- Cross-elbow stent placement for refractory arteriovenous fistula stenosis and chronic total occlusion in hemodialysis patients: a single-center retrospective cohort of 42 cases
- A systematic review and meta-analysis of the effects of non-pharmacological interventions in improving psychological status and sleep quality among hemodialysis patients
- Progress on the related mechanisms of vascular calcification in autogenous arteriovenous fistula in hemodialysis patients
- Ultrasound-guided angioplasty of arteriovenous fistula for hemodialysis: initial experience of a single center
- Exploratory Transcriptomic Profiling of Vein Tissue from Diabetic Patients Undergoing Arteriovenous Fistula Creation for Hemodialysis
BibTeX
@article{kejian2026current,
title = {{Current status of pharmacological interventions for preventing stenosis of arteriovenous hemodialysis access}},
author = {Wen Ke-jian and Gao Zhan-hui},
journal = {Linchuang shenzangbing zazhi},
year = {2026},
month = oct,
url = {http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2026.10.012},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Current status of pharmacological interventions for preventing stenosis of arteriovenous hemodialysis access
AU - Wen Ke-jian
AU - Gao Zhan-hui
PY - 2026
DA - 2026/10/24
JO - Linchuang shenzangbing zazhi
UR - http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2026.10.012
AB - Autogenous arteriovenous fistulas and arteriovenous grafts are currently the most commonly used types of hemodialysis vascular access. Vascular stenosis and secondary thrombosis are the major causes of vascular access dysfunction. At present， the management of vascular access dysfunction relies primarily on surgical interventions， including open surgery and endovascular treatment， whereas pharmacological strategies for prevention have not yet been incorporated into routine clinical practice. This review summarizes recent advances in pharmacological interventions for maintaining vascular access patency and preventing vascular stenosis， with the aim of exploring the potential role and clinical value of pharmacological strategies in preserving vascular access patency.
SN - 1671-2390
ER -